Microangiopathic hemolytic anemia natural history, complications and prognosis
Microangiopathic hemolytic anemia Microchapters |
Differentiating Microangiopathic hemolytic anemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Microangiopathic hemolytic anemia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia natural history, complications and prognosis |
FDA on Microangiopathic hemolytic anemia natural history, complications and prognosis |
on Microangiopathic hemolytic anemia natural history, complications and prognosis |
Microangiopathic hemolytic anemia natural history, complications and prognosis in the news |
Blogs on Microangiopathic hemolytic anemia natural history, complications and prognosis |
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
- If left untreated, 90% of patients with [[[microangiopathic hemolytic anemia]] may die[1].
- The prognosis can be improved with prompt treatment. Therapeutic plasmapheresis reduces mortality rate to 20%[1].
References
- ↑ 1.0 1.1 Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC; et al. (1991). "Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group". N Engl J Med. 325 (6): 393–7. doi:10.1056/NEJM199108083250604. PMID 2062330.